Curated News
By: NewsRamp Editorial Staff
September 29, 2026
Nanox.AI Expands UK Reach with Vertec Deal, Intel Optimization
TLDR
- Nanox.AI's exclusive UK reseller deal with Vertec Scientific and Intel optimization project position it to lead in AI-driven bone health diagnostics.
- Nanox.AI's HealthOST analyzes routine CT scans to detect vertebral fractures, with local inference via Intel optimization reducing cloud dependency.
- Nanox.AI's technology helps diagnose undetected vertebral fractures, potentially improving outcomes for thousands and making healthcare more proactive.
- Routine CT scans can reveal spinal and coronary issues beyond the original reason, and Nanox.AI is using AI to uncover these hidden findings.
Impact - Why it Matters
This news matters because it signals a potential breakthrough in the early detection of vertebral fractures, a condition that affects tens of thousands annually in the UK but often goes undiagnosed. By enabling routine CT scans to automatically flag spinal issues, Nanox.AI's HealthOST could lead to earlier treatment and better outcomes for patients. The exclusive reseller agreement with Vertec Scientific provides a direct commercial channel into the UK healthcare market, while the Intel collaboration addresses a critical barrier to AI adoption: the need for efficient, local processing that fits within hospital IT infrastructures. If successful, these moves could accelerate the integration of AI into everyday radiology, making advanced diagnostics more accessible and reducing the burden on healthcare systems. For investors, this demonstrates Nanox.AI's commitment to both innovation and commercialization, potentially driving revenue growth and strengthening its competitive position in the medical imaging AI space.
Summary
Nano-X Imaging Ltd. (NASDAQ: NNOX) is advancing its medical imaging AI business on two fronts through its subsidiary Nanox.AI. In a significant commercial move, Nanox.AI has signed an exclusive three-year UK reseller agreement with Vertec Scientific for its HealthOST bone solution, with minimum annual license commitments built into the deal. This partnership aims to address the approximately 86,000 vertebral fragility fractures that occur annually in the UK, most of which remain undiagnosed. HealthOST is designed to analyze routine CT scans to detect spinal and other anatomical findings that might otherwise go unnoticed, potentially enabling earlier intervention.
In a separate but complementary effort, Nanox.AI is collaborating with Intel on an optimization project that demonstrates a path for its imaging AI framework to run inference locally on hospital hardware rather than relying entirely on the cloud. This could reduce latency, improve data privacy, and lower costs for healthcare providers. Together, these initiatives highlight Nanox.AI's strategy to expand both the commercial reach and the technological capabilities of its AI solutions, positioning the company to capture a larger share of the growing medical imaging analytics market.
The news, covered by Nano-X Imaging Ltd. (NASDAQ: NNOX) and reported via InvestorWire, underscores the company's dual approach to growth. By securing a reseller agreement and advancing on-device AI, Nanox.AI is working to make its bone health solution more accessible and efficient for healthcare systems. For more details, readers can visit the company's newsroom at https://ibn.fm/NNOX.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, Nanox.AI Expands UK Reach with Vertec Deal, Intel Optimization
